BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 22288514)

  • 1. The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice.
    Kulis M; Chen X; Lew J; Wang Q; Patel OP; Zhuang Y; Murray KS; Duncan MW; Porterfield HS; W Burks A; Dreskin SC
    Clin Exp Allergy; 2012 Feb; 42(2):326-36. PubMed ID: 22288514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in mice.
    Liu Y; Sun Y; Chang LJ; Li N; Li H; Yu Y; Bryce PJ; Grammer LC; Schleimer RP; Zhu D
    J Allergy Clin Immunol; 2013 Jan; 131(1):213-21.e1-5. PubMed ID: 23199607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Ara h 2 to peanut-specific, immunoglobulin E-mediated, cell activation.
    McDermott RA; Porterfield HS; El Mezayen R; Burks AW; Pons L; Schlichting DG; Solomon B; Redzic JS; Harbeck RJ; Duncan MW; Hansen KC; Dreskin SC
    Clin Exp Allergy; 2007 May; 37(5):752-63. PubMed ID: 17456223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chemical modifications on allergenic potency of peanut proteins.
    Bencharitiwong R; van der Kleij HP; Koppelman SJ; Nowak-Węgrzyn A
    Allergy Asthma Proc; 2015; 36(3):185-91. PubMed ID: 25976435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ara h 2 and Ara h 6 have similar allergenic activity and are substantially redundant.
    Chen X; Wang Q; El-Mezayen R; Zhuang Y; Dreskin SC
    Int Arch Allergy Immunol; 2013; 160(3):251-8. PubMed ID: 23075924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effector activity of peanut allergens: a critical role for Ara h 2, Ara h 6, and their variants.
    Porterfield HS; Murray KS; Schlichting DG; Chen X; Hansen KC; Duncan MW; Dreskin SC
    Clin Exp Allergy; 2009 Jul; 39(7):1099-108. PubMed ID: 19438581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy using algal-produced Ara h 1 core domain suppresses peanut allergy in mice.
    Gregory JA; Shepley-McTaggart A; Umpierrez M; Hurlburt BK; Maleki SJ; Sampson HA; Mayfield SP; Berin MC
    Plant Biotechnol J; 2016 Jul; 14(7):1541-50. PubMed ID: 26801740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.
    Patil SU; Steinbrecher J; Calatroni A; Smith N; Ma A; Ruiter B; Virkud Y; Schneider M; Shreffler WG
    J Allergy Clin Immunol; 2019 Nov; 144(5):1310-1319.e4. PubMed ID: 31377342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capacity of purified peanut allergens to induce degranulation in a functional in vitro assay: Ara h 2 and Ara h 6 are the most efficient elicitors.
    Blanc F; Adel-Patient K; Drumare MF; Paty E; Wal JM; Bernard H
    Clin Exp Allergy; 2009 Aug; 39(8):1277-85. PubMed ID: 19538351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ara h 6 complements Ara h 2 as an important marker for IgE reactivity to peanut.
    Koid AE; Chapman MD; Hamilton RG; van Ree R; Versteeg SA; Dreskin SC; Koppelman SJ; Wünschmann S
    J Agric Food Chem; 2014 Jan; 62(1):206-13. PubMed ID: 24328145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Component-resolved IgE profiles in Austrian patients with a convincing history of peanut allergy.
    Ackerbauer D; Bublin M; Radauer C; Varga EM; Hafner C; Ebner C; Szépfalusi Z; Fröschl R; Hoffmann-Sommergruber K; Eiwegger T; Breiteneder H
    Int Arch Allergy Immunol; 2015; 166(1):13-24. PubMed ID: 25765158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of Ara h1, Ara h2 and Ara h3 in peanut-allergic patients, as determined by immunoglobulin E Western blotting, basophil-histamine release and intracutaneous testing: Ara h2 is the most important peanut allergen.
    Koppelman SJ; Wensing M; Ertmann M; Knulst AC; Knol EF
    Clin Exp Allergy; 2004 Apr; 34(4):583-90. PubMed ID: 15080811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ara h 2 and Ara 6 are the best predictors of severe peanut allergy: a double-blind placebo-controlled study.
    Kukkonen AK; Pelkonen AS; Mäkinen-Kiljunen S; Voutilainen H; Mäkelä MJ
    Allergy; 2015 Oct; 70(10):1239-45. PubMed ID: 26095653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The non-specific lipid transfer protein, Ara h 9, is an important allergen in peanut.
    Lauer I; Dueringer N; Pokoj S; Rehm S; Zoccatelli G; Reese G; Miguel-Moncin MS; Cistero-Bahima A; Enrique E; Lidholm J; Vieths S; Scheurer S
    Clin Exp Allergy; 2009 Sep; 39(9):1427-37. PubMed ID: 19624524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring Ara h 1, 2 and 3-sIgE and sIgG4 antibodies in peanut allergic children receiving oral rush immunotherapy.
    Nozawa A; Okamoto Y; Movérare R; Borres MP; Kurihara K
    Pediatr Allergy Immunol; 2014 Jun; 25(4):323-8. PubMed ID: 24953293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses.
    Li XM; Serebrisky D; Lee SY; Huang CK; Bardina L; Schofield BH; Stanley JS; Burks AW; Bannon GA; Sampson HA
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):150-8. PubMed ID: 10887318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the effector activity of Ara h 2 and Ara h 6 by selective depletion from a crude peanut extract.
    Chen X; Zhuang Y; Wang Q; Moutsoglou D; Ruiz G; Yen SE; Dreskin SC
    J Immunol Methods; 2011 Sep; 372(1-2):65-70. PubMed ID: 21777590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and stability of 2S albumin-type peanut allergens: implications for the severity of peanut allergic reactions.
    Lehmann K; Schweimer K; Reese G; Randow S; Suhr M; Becker WM; Vieths S; Rösch P
    Biochem J; 2006 May; 395(3):463-72. PubMed ID: 16372900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of age on IgE response in peanut-allergic children and adolescents from the Mediterranean area.
    Garcia-Blanca A; Aranda A; Blanca-Lopez N; Perez D; Gomez F; Mayorga C; Torres MJ; Diaz-Perales A; Perkins JR; Villalba M; Blanca M; Canto G
    Pediatr Allergy Immunol; 2015 Sep; 26(6):497-502. PubMed ID: 26046378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy.
    Wood RA; Sicherer SH; Burks AW; Grishin A; Henning AK; Lindblad R; Stablein D; Sampson HA
    Allergy; 2013 Jun; 68(6):803-8. PubMed ID: 23621498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.